mutation (8%), and 3/62 patients with BRCA2 (5%). Overall,16/24 patients (67%) were surgically treated for their cancer.
INTRODUCTION AND OBJECTIVES: Targeted screening in high risk families due to familial aggregation, is recommended as early as 40-45 years in first degree relatives (FDR) of prostate cancer (PCa) patients according to high risk and early onset of the disease. We aimed to assess this concept in FDR 40-49 years old (yo).
METHODS: We obtained a serum PSA testing, yearly, in a 8-year PCa screening program, in 345 FDR (brothers or sons), 40-49 yo, of PCa patients treated, between 1994 40-49 yo, of PCa patients treated, between -1997 . A systematic genealogical analysis previously performed, allowed to define the familial PCa status: at least 1 PCa in the family (range: 1-7), so the screened men were classified into: hereditary status (3+ PCa:11.3%), familial without obvious hereditary pattern (2 PCa:19.2%) or sporadic (1 PCa:69.5%). Prostatic biopsies (PBx) were performed when PSA >4ng/mL, until 2002, while when PSA >2.5ng/mL therafter.
RESULTS: Mean age at screening was 45.5y. A total of 1344 screening tests were performed during this program (Table) . Of the 345 screened men, 21 (6%) had at least one PSA level > 4 ng/ml of the 8 assessments (Table) . PBx: diagnosed 7 PCa (2%) in 41, 43, 44, 45, 46 and 48 (2 cases) yo men, were negative in 5 relatives, were not done in 9 cases (1 refusal, 2 due to other medical problem, 6 due to control PSA <4ng/ml including 3 cases <2.5ng.ml). The positive predictive value of PSA >4ng/mL was 7/12 (58%). The proportion of men with PSA >4ng/ mL in 2+ PCa families was significantly higher than in sporadic families: 2.9% vs 0.9% (p¼0.013). In addition, 37 relatives (10.7%) had at least one PSA level >2.5ng/mL and <4ng/mL, and PBx diagnosed 2 more PCa (43 and 47 yo.) and most frequently were not done due to not indicated at that time (before 2003). Of the 208 relatives with PSA <1ng/mL at baseline: none had PSA >2.5ng/mL during the 4 consecutive years, while 7 had PSA >2.5ng/mL at 6th round (n¼2), 7th round (n¼4) and 8th round (n¼1), the latter being diagnosed with PCa at 50 yo.
CONCLUSIONS: Those results suggest that PCa is not frequent in 40-49 yo. FDR, however diagnosed in 9/345 (2.6%) of cases of whom 4 times before 45 y. Therefore we recommend to start screening as soon as 40 yo. in high risk families with annual PSA testing, except when baseline PSA is <1ng/mL case in which next PSA testing may be performed 5 years later. INTRODUCTION AND OBJECTIVES: Current tissue-based prognostic biomarker assays claim that genetic assessment of a single focus is sufficient to predict disease behavior. We analyzed and compared the genetic profiles of multifocal prostate cancer (PCa) with concordant lymph node metastasis (LNM) to determine if expression based prognostic tests are robust to multifocality.
Source of
METHODS: This IRB-approved study comprised patients who underwent radical prostatectomy and lymph node dissection that revealed N1 disease or discordant multifocal disease (low-and highgrade foci). DNA and RNA were co-isolated from each tumor focus preidentified on formalin fixed paraffin embedded specimens. High depth, targeted DNA and RNA next generation sequencing was performed to characterize the genetic and transcriptional signature of each sample, using the Oncomine Comprehensive (11 patients) or Comprehensive Cancer (DNA, 3 patients) Panels and a custom targeted RNAseq panel comprising genes for deriving prognostic signatures.
RESULTS: A total of 67 primary tumor and 17 LMN foci (with control tissue when available) from 14 patients were analyzed. We observed significant intra-and inter-patient molecular heterogeneity. For example, in patient #1, while all four regions of high-grade primary tumor showed TP53 somatic mutations and some broad copy number alterations (CNAs) with two samples from the LNM, tumor areas near the positive margin showed more complete concordance than intraprostatic regions. Critically, a low-grade primary tumor focus in this case showed no somatic mutation or CNA overlap with the high-grade or LNM samples. In patient #4, all tumor and LNM foci shared a large number of somatic mutations, including a frameshift mutation in PTEN, with no high level CNA identified, consistent with a hypermutated genotype. By targeted RNAseq, low-grade and high-grade tumors from e132 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 the same patient showed distinct expression profiles using genes included in available prognostic signatures (Figure 1) . CONCLUSIONS: Our results challenge the claim that expression based prognostic tests are robust to multifocality. Additional molecular studies are needed to better characterize the biologically dominant lesion in multi-focal PCa and hold promise for the development of improved prognostic biomarkers. Rectovaginal and J-pouch vaginal fistulae are abnormal epithelialized connections between the rectum or J-pouch to the vagina. Symptoms, such as fecal incontinence, can be distressing to patients. These fistulae can be a challenge to repair and multiple repair methods have been described in the literature including transvaginal, transrectal, and flap interposition repairs. Success rates in the literature range from 10-100% and with each subsequent repair the success rate of closure decreases.
METHODS: We present the case of a 35 year-old woman with a history of ulcerative colitis who developed a fistula following a total proctocolectomy and ileal-anal pouch anastomosis. When she presented she had already undergone more than ten attempts at repair. Prior to our fisula repair she had a fecal diversion with a loop ileostomy. We performed a transvaginal repair utilizing a gracilis muscle interposition flap. Indocyanine green was given intravenously and the SPY Elite imaging system was used to enable the visualization of microvascular blood flow and perfusion to the gracilis flap and to the bed of the fistula repair intraoperatively. RESULTS: Our patient did well after the procedure. She was discharged home with the foley in place on post-operative day 1. At her one month follow-up the repair was intact and she was healing well.
CONCLUSIONS: In cases of complex rectovaginal and vaginal J-pouch fistulae, especially those that are reoperative cases, fistula repair with a gracilis interposition flap is a viable repair option. Success from this repair can be aided by assuring complete excision of nonviable tissue and a healthy flap. In our case these steps were aided by the use of the SPY Elite imaging system. The reclassification of vaginal mesh to a high risk device for treatment of pelvic organ prolapse prompted our group to consider alternative graft materials. Based on the similar success rates and durability of mesh and autologous fascia in the treatment of female stress urinary incontinence (SUI), our objective was to develop a transvaginal repair for anterior and apical vaginal prolapse with the use of only autologous fascia lata graft thereby avoiding synthetic mesh, allograft and xenograft.
METHODS: The video demonstrates our technique for Autologous Anterior and Apical Pelvic Organ Prolapse (AAA-POP) repair. Autologous fascia lata of suitable size (4 X 12 cm up to 5 X 14 cm) is harvested through a minimally invasive, lateral upper thigh incision. The graft is then cut into 3 strips (1cm X 12cm up to 1.3 cm X 14cm) and reassembled with one strip affixed to the bladder neck and sutured to the obturator internus fascia with 0-vicryl. The other 2 strips are sutured to the strip at the bladder neck with CV-2 Gore-Tex suture, crossed at the level of the vaginal apex, and sutured to the sacrospinous ligaments with 0-PDS. Patients were followed with subjective SEAPI scores, visual analog pain (VAP) scores (range 0-10), pelvic examination (BadenWalker grading), and examination of the thigh harvest site.
RESULTS: The AAA-POP procedure has been performed on 5 patients with a mean age of 61 and a mean follow-up of 2 months. Apical uterine suspension was performed in 3/5 patients and the other 2/5 patients were status post hysterectomy. Symptoms of pelvic organ prolapse resolved in all 5 patients, but 1 patient had an asymptomatic grade 1 cystocele without apical prolapse at 3 months follow-up. No patients complained of SUI or urge incontinence on SEAPI scoring. 1 patient required lysis of a concurrent pubovaginal sling 2 weeks postoperatively with resolution of urinary retention, and 1 patient had mild obstructive symptoms on SEAPI scoring. 2 patients developed thigh hernias postoperatively, and the mean VAP score at the harvest site was 1.8 for all patients.
CONCLUSIONS: Autologous Anterior and Apical Pelvic Organ Prolapse (AAA-POP) repair with fascia lata is a feasible option in the post-mesh era and appears to be safe and efficacious with short-term follow-up. Longer follow-up is needed to determine long term success and possible complications of the procedure. Although self-reported pain scores were low, patients should be aware of the risk of residual pain at the harvest site and possible development of a thigh hernia.
Source of Funding: None

V2-03 ROBOT-ASSISTED REPAIR OF SUPRATRIGONAL VESICOVAGINAL FISTULAE USING A PERITONEAL FLAP INLAY
Christoph Schregel*, Beatrice Breu, Kevin Horton, Hubert John, Winterthur, Switzerland INTRODUCTION AND OBJECTIVES: Vesicovaginal fistulae (VVF) represent a major health-care problem in low-resourced countries, where most VVF derive from obstetric complications. In the western world, most VVF occur after difficult hysterectomies. A transvaginal approach can be used successfully in low and simple fistulae, while supratrigonal and more complex cases may require a transabdominal approach. To minimize operation trauma laparoscopic or robot-assisted techniques are being used. Though fistulae closure with Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 THE JOURNAL OF UROLOGY â e133
